GENE ONLINE|News &
Opinion
Blog

Oncology
Funding Oncology
China’s Hengrui Buds Off New Biotech With 11 Therapeutic Programs
2022-05-19
Deals Oncology
All Blue Capital Recruits Former AstraZeneca Oncology Head to Sweeten Zymeworks Deal
2022-05-04
Trials & Approvals Biosimilar
Alymsys Becomes the Third Biosimilar for Bevacizumab Approved by FDA
2022-04-20
M&A Oncology
GSK to Acquire Biopharmaceutical Company Sierra Oncology for $1.9B
2022-04-17
China Takeda Pharmaceutical
Shanghai’s Hasten Seals $322 Million Acquisition of Takeda Drugs
2022-04-06
M&A Biosimilar
BBL to Take Over Biosimilars Business from Viatris 
2022-03-02
Deals Oncology
China’s Hansoh Teams Up with Middle East Onco-Collaborator
2022-01-02
IPO BeiGene
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Funding Precision Medicine
Acrivon Therapeutics to Advance Proteomics Platform & Oncology Pipeline with $100M Series B Financing
2021-11-12
China CSCO
2021 CSCO Highlights: JW Therapeutics, Innovent, Ambrx, HUTCHMED Release Latest Data on Cancer Drugs
2021-10-07
Funding Small Molecule Drug
858 Therapeutics Launches with $60 Million Series A for Advancing Small-Molecule Drugs
2021-09-23
Trials & Approvals Prostate Cancer
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
Trials & Approvals Rare Disease
Merck Fortifies Oncology Pipeline with FDA Win for HIF-2α Inhibitor, Welireg
2021-08-17
M&A Chemoproteomics
Bayer Spends $2 Billion to Acquire a Startup on the Brink of an IPO
2021-08-05
China
Zai Lab, Schrödinger Collaborate to Advance Cancer Program
2021-08-05
1 2 3 4 5 6
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top